Viewing Study NCT04685135

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 10:33 PM
Ignite Modification Date: 2026-01-05 @ 5:33 PM
Study NCT ID: NCT04685135
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-01-22
First Post: 2020-12-21
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation
Sponsor: Mirati Therapeutics Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Non Small Cell Lung Cancer View
None Advanced Non Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None KRAS G12C View
None Non-small cell lung cancer View
None NSCLC View
None Metastatic Cancer View
None Docetaxel View
None Phase 3 Clinical Trial View
None Adagrasib View
None KRAS View
None KRAZATI View